Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraoperative Hyoscine Butylbromide During Laparoscopic Transcystic Papillary Balloon Dilation for Choledocholithiasis: A Prospective Interventional Study With Historical Controls

NCT07814976 is registered in ClinicalTrials.gov with Riga East Clinical University Hospital as lead sponsor.

NCT NCT07814976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07814976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraoperative Hyoscine Butylbromide During Laparoscopic Transcystic Papillary Balloon Dilation for Choledocholithiasis: A Prospective Interventional Study With Historical Controls
Lead sponsor
Riga East Clinical University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
January 4, 2026
Completion date
February 1, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

choledocholithiasis, common bile duct stones